The Highly Potent AhR Agonist Picoberin Modulates Hh-Dependent Osteoblast Differentiation.

ABSTRACT: Identification and analysis of small molecule bioactivity in target-agnostic cellular assays and monitoring changes in phenotype followed by identification of the biological target are a powerful approach for the identification of novel bioactive chemical matter in particular when the monitored phenotype is disease-related and physiologically relevant. Profiling methods that enable the unbiased analysis of compound-perturbed states can suggest mechanisms of action or even targets for bioactive small molecules and may yield novel insights into biology. Here we report the enantioselective synthesis of natural-product-inspired 8-oxotetrahydroprotoberberines and the identification of Picoberin, a low picomolar inhibitor of Hedgehog (Hh)-induced osteoblast differentiation. Global transcriptome

SUBMITTER: Flegel J 

PROVIDER: S-EPMC9791665 | biostudies-literature | 2022 Dec

REPOSITORIES: biostudies-literature